| Apr 3, 2011 |
Apr 5, 2011 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
22.5
|
-9,380
|
-6.34%
|
✗
|
$103.4K |
| Mar 30, 2011 |
Apr 1, 2011 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
77.5
|
+1,614
|
1.35%
|
✗
|
$9.5K |
| Jan 17, 2011 |
Jan 28, 2011 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
87.5
|
+21,935
|
4.46%
|
✗
|
$153.1K |
| Nov 23, 2010 |
Nov 24, 2010 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
36.3
|
-1,063
|
-0.77%
|
✗
|
$11.6K |
| Sep 15, 2010 |
Sep 17, 2010 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
17.5
|
-258,900
|
-48.38%
|
✗
|
$2.8M |
| Sep 2, 2010 |
Sep 7, 2010 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
22.5
|
-7,084
|
-9.84%
|
✗
|
$74.9K |
| Apr 3, 2010 |
Apr 13, 2010 |
ENZON PHARMACEUTICALS, INC.
|
President |
Sell |
22.5
|
-7,035
|
-11.92%
|
✗
|
$73.7K |
| Feb 22, 2010 |
Feb 24, 2010 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, CSO |
Sell |
20.0
|
-101,329
|
-72.13%
|
✗
|
$942.6K |
| Jan 17, 2010 |
Jan 20, 2010 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, Chief Scientific Off |
Sell |
87.5
|
+16,613
|
4.42%
|
✗
|
$109.7K |
| Nov 23, 2009 |
Nov 25, 2009 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, Chief Sci. Officer |
Sell |
37.5
|
-797
|
-0.59%
|
✗
|
$8.3K |
| Sep 2, 2009 |
Sep 4, 2009 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, Chief Sci Officer |
Sell |
26.3
|
-5,313
|
-3.85%
|
✗
|
$40.3K |
| Apr 3, 2009 |
Apr 7, 2009 |
ENZON PHARMACEUTICALS, INC.
|
EVP, R&D, Chief Scientific Off |
Sell |
26.3
|
-7,035
|
-5.41%
|
✗
|
$43.1K |
| Mar 7, 2006 |
Mar 7, 2006 |
ENZON PHARMACEUTICALS, INC.
|
EVP-R&D & Chief Scien. Officer |
Buy |
91.3
|
+3,000
|
54.55%
|
✗
|
$20.6K |
| Oct 4, 2005 |
Oct 5, 2005 |
ENZON PHARMACEUTICALS, INC.
|
EVP-R&D & Chief Scien. Officer |
Buy |
91.3
|
+5,500
|
100.00%
|
✗
|
$39.5K |